| Literature DB >> 34505002 |
Bo Peng1, Rowland W Pettit1, Christopher I Amos1.
Abstract
OBJECTIVES: We developed COVID-19 Outbreak Simulator (https://ictr.github.io/covid19-outbreak-simulator/) to quantitatively estimate the effectiveness of preventative and interventive measures to prevent and battle COVID-19 outbreaks for specific populations.Entities:
Keywords: COVID-19; Continuity planning; Risk assessment; Simulation
Year: 2021 PMID: 34505002 PMCID: PMC7928848 DOI: 10.1093/jamiaopen/ooaa074
Source DB: PubMed Journal: JAMIA Open ISSN: 2574-2531
System provided plugins and their features
| Name | Features |
|---|---|
| init | Initialize population with a specified incidence rate and/or seroprevalence. |
| setparam | Change model parameters during the course of the simulation. |
| stat | Output population and subpopulation statistics, such as incidence rate. |
| sample | Calculate statistics from a sample drawn from the population. |
| insert | Addition of individuals to the population. |
| remove | Removal of individuals from the population. |
| move | Move individuals from one subpopulation to another. |
| quarantine | Quarantine all or infected individuals for a specified duration. |
| testing | Test all or selected individuals with a test with specified sensitivity, specificity, limit of detection, and turnaround time. |
| community_infection | Infect all or selected individuals with a specified probability. |
Figure 1.(A) Probability of transmission per day for a symptomatic case with an incubation period of 4 days (purple line) and for an asymptomatic case (green line). (B) Distribution of serial intervals of 10 000 simulated infector-infected individual pairs.
Figure 3.Diagram of a quarantine process with one test performed before the end of quarantine, with the command to implement the simulation listed below. Briefly, (1) a population is initialized with an incidence rate of 1 so everyone is infected. A random lead time is used so that symptomatic cases are anywhere in their incubation period, and asymptomatic carriers are anywhere in their course of infections. (2) Everyone is quarantined for 10 days regardless of they have shown symptoms. (3) A SARS-CoV-2 test with a sensitivity of 95% and specificity of 99% is applied to everyone on day 9. The test results will be available at the end of quarantine due and people who test negative will be isolated. (4) People who show symptoms during quarantine will be isolated.
Figure 2.Duration versus remaining population size for 10 000 simulated outbreaks. (A) The virus carrier was introduced to the population as long as he or she did not show any symptoms. (B) The virus carrier was introduced to the population after 7-day quarantine.
The effectiveness of periodic PCR-based tests in reducing within-lab infections
| Lab size | Test frequency | Average lab size after 90 days | Proportion of uninfected labs | Average number of community infections | Average number of within-lab transmissions |
|---|---|---|---|---|---|
| 10 | 3 | 5.9 | 1.14% | 3.6 | 0.5 |
| 10 | 7 | 5.2 | 1.14% | 3.4 | 1.5 |
| 10 | 14 | 4.5 | 1.15% | 3.1 | 2.4 |
| 10 | No test | 3.7 | 1.01% | 2.9 | 3.5 |
| 20 | 3 | 11.8 | 0.02% | 7.1 | 1.2 |
| 20 | 7 | 10.1 | 0.03% | 6.6 | 3.3 |
| 20 | 14 | 8.3 | 0.00% | 6.1 | 5.6 |
| 20 | No test | 6.2 | 0.00% | 5.3 | 8.5 |
| 30 | 3 | 17.6 | 0.00% | 10.6 | 1.9 |
| 30 | 7 | 15 | 0.00% | 9.9 | 5.2 |
| 30 | 14 | 12 | 0.00% | 9 | 9 |
| 30 | No test | 8.5 | 0.00% | 7.7 | 13.8 |
All simulations assumed a daily probability of community infection of 0.0022. Results for each scenario are based on 10 000 replicate simulations.